This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Beats Q4 Earnings Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 1.49% and 1.41%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Top Research Reports for Visa, AbbVie & Analog Devices
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI), as well as a micro-cap stock Precipio, Inc. (PRPO).
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
by Zacks Equity Research
The report comes at a time when insurers are grappling with rising medical costs.
5 Stocks You Must Watch for Earnings This Week
by Tracey Ryniec
Hint: They aren't all banks.
What Lies Ahead for Dow ETF in Q4 Earnings?
by Sweta Killa
The Dow Jones is performing better amid the rise in Treasury yields and the tech sell-off. The trend might continue as we head into the fourth-quarter earnings season.
Stock Market News for Jan 14, 2025
by Zacks Equity Research
Wall Street closed mixed on Monday, driven by energy and healthcare stocks.
Big Gains Ahead for Medicare Advantage Sellers as Payments Set to Grow
by Kaibalya Pravo Dey
As the largest MA plan sellers, UnitedHealth, Humana and CVS Health collectively account for nearly 60% of the market.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
What Analyst Projections for Key Metrics Reveal About UnitedHealth (UNH) Q4 Earnings
by Zacks Equity Research
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
UnitedHealth Stock Q4 Earnings Preview: Buy Now or Wait for Results?
by Kaibalya Pravo Dey
UNH's fourth-quarter earnings are likely to have benefited from growing premiums and service revenues.
Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene
by Zacks Equity Research
UnitedHealth, Humana and Centene have been highlighted in this Industry Outlook article.
Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 HMO Stocks Poised to Thrive Despite Industry Headwinds
by Debasmita Chatterjee
The Medical-HMO industry benefits from a growing customer base and contract wins. However, industry challenges like rising costs and workforce shortages remain a concern. UNH, HUM and CNC are likely to navigate industry storms.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Stock Market News for Jan 10, 2025
by Zacks Equity Research
Wall Street remains volatile since the beginning of 2025.
UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through
by Zacks Equity Research
UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News for Jan 9, 2025
by Zacks Equity Research
U.S. stock markets closed mixed on Wednesday after a choppy session.
UnitedHealth Group (UNH) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $513.67, moving +0.13% from the previous trading session.
Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping?
by Kaibalya Pravo Dey
Improving the consumer experience, engagement and trust is emerging as a top strategy for healthcare companies.
The Zacks Analyst Blog Highlights UnitedHealth, Costco Wholesale, IBM and Smith-Midland
by Zacks Equity Research
UnitedHealth, Costco Wholesale, IBM and Smith-Midland are part of the Zacks top Analyst Blog.
Top Stock Reports for UnitedHealth, Costco & IBM
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Costco Wholesale Corporation (COST) and International Business Machines Corporation (IBM), as well as a micro-cap stock Smith-Midland Corporation (SMID).
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth Group (UNH) Stock Moves -0.38%: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $505.86, marking a -0.38% move from the previous day.